The m5C methyltransferase NSUN2 promotes codon‐dependent oncogenic translation by stabilising tRNA in anaplastic thyroid cancer
Open Access
- 20 November 2023
- journal article
- research article
- Published by Wiley in Clinical and Translational Medicine
- Vol. 13 (11) , e1466
Abstract
Background: Translation dysregulation plays a crucial role in tumourigenesis and cancer progression. Oncogenic translation relies on the stability and availability of tRNAs for protein synthesis, making them potential targets for cancer therapy.Methods: This study performed immunohistochemistry analysis to assess NSUN2 levels in thyroid cancer. Furthermore, to elucidate the impact of NSUN2 on anaplastic thyroid cancer (ATC) malignancy, phenotypic assays were conducted. Drug inhibition and time‐dependent plots were employed to analyse drug resistance. Liquid chromatography–mass spectrometry and bisulphite sequencing were used to investigate the m5C methylation of tRNA at both global and single‐base levels. Puromycin intake and high‐frequency codon reporter assays verified the protein translation level. By combining mRNA and ribosome profiling, a series of downstream proteins and codon usage bias were identified. The acquired data were further validated by tRNA sequencing.Results: This study observed that the tRNA m5C methyltransferase NSUN2 was up‐regulated in ATC and is associated with dedifferentiation. Furthermore, NSUN2 knockdown repressed ATC formation, proliferation, invasion and migration both in vivo and in vitro. Moreover, NSUN2 repression enhanced the sensitivity of ATC to genotoxic drugs. Mechanically, NSUN2 catalyses tRNA structure‐related m5C modification, stabilising tRNA that maintains homeostasis and rapidly transports amino acids, particularly leucine. This stable tRNA has a substantially increased efficiency necessary to support a pro‐cancer translation program including c‐Myc, BCL2, RAB31, JUNB and TRAF2. Additionally, the NSUN2‐mediated variations in m5C levels and different tRNA Leu iso‐decoder families, partially contribute to a codon‐dependent translation bias. Surprisingly, targeting NSUN2 disrupted the c‐Myc to NSUN2 cycle in ATC.Conclusions: This research revealed that a pro‐tumour m5C methyltransferase, dynamic tRNA stability regulation and downstream oncogenes, c‐Myc, elicits a codon‐dependent oncogenic translation network that enhances ATC growth and formation. Furthermore, it provides new opportunities for targeting translation reprogramming in cancer cells.Keywords
Funding Information
- National Natural Science Foundation of China (82270835)
This publication has 104 references indexed in Scilit:
- RNA cytosine methylation by Dnmt2 and NSun2 promotes tRNA stability and protein synthesisNature Structural & Molecular Biology, 2012
- The ribosome profiling strategy for monitoring translation in vivo by deep sequencing of ribosome-protected mRNA fragmentsNature Protocols, 2012
- A general method to derive robust organ-specific gene expression-based differentiation indices: application to thyroid cancer diagnosticOncogene, 2012
- Angiogenin-Induced tRNA Fragments Inhibit Translation InitiationMolecular Cell, 2011
- RNA methylation by Dnmt2 protects transfer RNAs against stress-induced cleavageGenes & Development, 2010
- Angiogenin cleaves tRNA and promotes stress-induced translational repressionJournal of Cell Biology, 2009
- Enhanced antitumor efficacy of cisplatin in combination with HemoHIM in tumor-bearing miceBMC Cancer, 2009
- RNA cytosine methylation analysis by bisulfite sequencingNucleic Acids Research, 2008
- Identification of human tRNA:m5C methyltransferase catalysing intron-dependent m5C formation in the first position of the anticodon of the ${\hbox{ pre-tRNA }}_{\left(\hbox{ CAA }\right)}^{\hbox{ Leu }}$Nucleic Acids Research, 2006
- The ‘effective number of codons’ used in a geneGene, 1990